| 2019 | S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
| CANCER RESEARCH AND TREATMENT |
| 2008 | S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2023 | Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study
| MOLECULAR CANCER THERAPEUTICS |
| 2013 | Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program | UROLOGY |
| 2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2020 | Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma
| DIAGNOSTICS |
| 2018 | Screening audit' as a quality assurance tool in good clinical practice compliant research environments
| BMC MEDICAL ETHICS |
| 2024 | Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study | GASTRIC CANCER |
| 2022 | Self-efficacy for coping with cancer and quality of life in advanced gastric cancer patients | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
| 1996 | Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression | CLINICAL & EXPERIMENTAL METASTASIS |
| 1997 | Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression | BREAST CANCER RESEARCH AND TREATMENT |
| 2021 | SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence
| GASTRIC CANCER |
| 2015 | Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas | GUT |
| 2019 | Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2006 | Significant Gene Selection Using Integrated Microarray Data Set with Batch Effect
| Genomics & Informatics |
| 2023 | Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study | HEPATOLOGY |
| 2008 | SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis.
| BMC BIOINFORMATICS |
| 2023 | Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
| NEW ENGLAND JOURNAL OF MEDICINE |
| 2019 | Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy | SUPPORTIVE CARE IN CANCER |
| 2021 | Stable Symptom Clusters and Evolving Symptom Networks in Relation to Chemotherapy Cycles | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT |
| 2004 | Statistical methods of determining a cut off value between normal and disease groups
| Bulletin of Informatics and Cybernetics |
| 2023 | Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20)
| CANCER RESEARCH AND TREATMENT |
| 2009 | Subtelomeric DNA methylation and telomere length in human cancer cells | CANCER LETTERS |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | ONCOLOGY |
| 2008 | Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
| ANNALS OF ONCOLOGY |
| 2014 | Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. | EUROPEAN UROLOGY |
| 2017 | Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life | SUPPORTIVE CARE IN CANCER |
| 1998 | Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates with gastric cancer progression
| YONSEI MEDICAL JOURNAL |
| 2020 | Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells
| YONSEI MEDICAL JOURNAL |
| 2011 | Systematic analyses of genes associated with radiosensitizing effect by celecoxib, a specific cyclooxygenase-2 inhibitor
| JOURNAL OF RADIATION RESEARCH |
| 2006 | Systematic analysis of cDNA microarray-based CGH. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 1998 | Telomerase Activity and Telomere Lengths in Various Cell Lines: Changes of Telomerase Activity Can Be Another Method for Chemosensitivity Evaluation | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2017 | Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2013 | Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2019 | Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
| CANCER RESEARCH AND TREATMENT |
| 2018 | The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control | CANCER NURSING |
| 2019 | The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer.
| GASTRIC CANCER |
| 2010 | The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up | ANNALS OF SURGICAL ONCOLOGY |
| 2010 | The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2015 | The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2008 | The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2014 | The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. | MOLECULAR CANCER THERAPEUTICS |
| 2009 | The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2022 | The Essentials of Multiomics
| ONCOLOGIST |
| 2013 | The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
| YONSEI MEDICAL JOURNAL |
| 2014 | The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium.
| EUROPEAN UROLOGY |
| 2015 | The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study | LANCET ONCOLOGY |
| 2007 | The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation | ONCOGENE |
| 2014 | The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation.
| MOLECULAR CANCER RESEARCH |
| 2004 | The pattern of gene copy number changes in bilateral breast cancer surveyed by cDNA microarray-based comparative genomic hybridization. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | GASTRIC CANCER |
| 2007 | The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas
| LABORATORY INVESTIGATION |
| 2022 | The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
| Genomics & Informatics |
| 2013 | Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2005 | Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents | BIOCHEMICAL PHARMACOLOGY |
| 2000 | Tissue urokinase-type plasminogen activator receptor levels in breast cancer | International Journal of Molecular Medicine |
| 2021 | Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
| ONCOLOGIST |
| 2020 | Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells
| Genomics & Informatics |
| 2023 | Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer | JOURNAL OF CLINICAL ONCOLOGY |
| 2002 | Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. | BRITISH JOURNAL OF SURGERY |
